Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZYDUS LIFESCIENCES vs GLENMARK PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZYDUS LIFESCIENCES GLENMARK PHARMA ZYDUS LIFESCIENCES/
GLENMARK PHARMA
 
P/E (TTM) x 20.0 12.7 158.2% View Chart
P/BV x 2.4 1.6 147.3% View Chart
Dividend Yield % 0.6 0.6 100.9%  

Financials

 ZYDUS LIFESCIENCES   GLENMARK PHARMA
EQUITY SHARE DATA
    ZYDUS LIFESCIENCES
Mar-22
GLENMARK PHARMA
Mar-21
ZYDUS LIFESCIENCES/
GLENMARK PHARMA
5-Yr Chart
Click to enlarge
High Rs674573 117.6%   
Low Rs331195 169.5%   
Sales per share (Unadj.) Rs149.1387.8 38.4%  
Earnings per share (Unadj.) Rs22.734.4 66.1%  
Cash flow per share (Unadj.) Rs29.750.1 59.3%  
Dividends per share (Unadj.) Rs2.502.50 100.0%  
Avg Dividend yield %0.50.7 76.4%  
Book value per share (Unadj.) Rs166.1249.6 66.5%  
Shares outstanding (eoy) m1,023.74282.17 362.8%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.41.0 340.3%   
Avg P/E ratio x22.111.2 197.9%  
P/CF ratio (eoy) x16.97.7 220.8%  
Price / Book Value ratio x3.01.5 196.6%  
Dividend payout %11.07.3 151.3%   
Avg Mkt Cap Rs m514,277108,353 474.6%   
No. of employees `000NANA-   
Total wages/salary Rs m21,77723,437 92.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m152,652109,439 139.5%  
Other income Rs m2,354502 468.8%   
Total revenues Rs m155,006109,941 141.0%   
Gross profit Rs m34,42721,289 161.7%  
Depreciation Rs m7,1304,436 160.7%   
Interest Rs m1,2703,531 36.0%   
Profit before tax Rs m28,38113,825 205.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,1174,124 124.1%   
Profit after tax Rs m23,2649,701 239.8%  
Gross profit margin %22.619.5 115.9%  
Effective tax rate %18.029.8 60.4%   
Net profit margin %15.28.9 171.9%  
BALANCE SHEET DATA
Current assets Rs m122,61473,596 166.6%   
Current liabilities Rs m78,39442,010 186.6%   
Net working cap to sales %29.028.9 100.4%  
Current ratio x1.61.8 89.3%  
Inventory Days Days937 1,398.1%  
Debtors Days Days8086 93.1%  
Net fixed assets Rs m144,38267,093 215.2%   
Share capital Rs m1,024282 362.9%   
"Free" reserves Rs m168,97270,148 240.9%   
Net worth Rs m169,99670,430 241.4%   
Long term debt Rs m3,62138,888 9.3%   
Total assets Rs m266,996140,689 189.8%  
Interest coverage x23.34.9 475.0%   
Debt to equity ratio x00.6 3.9%  
Sales to assets ratio x0.60.8 73.5%   
Return on assets %9.29.4 97.7%  
Return on equity %13.713.8 99.4%  
Return on capital %17.115.9 107.6%  
Exports to sales %00-   
Imports to sales %14.30-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs m21,869NA-   
Fx inflow Rs m63,06535,753 176.4%   
Fx outflow Rs m21,86912,023 181.9%   
Net fx Rs m41,19623,729 173.6%   
CASH FLOW
From Operations Rs m21,04111,312 186.0%  
From Investments Rs m11,544-6,752 -171.0%  
From Financial Activity Rs m-8,683-4,418 196.5%  
Net Cashflow Rs m23,729278 8,529.5%  

Share Holding

Indian Promoters % 74.9 46.7 160.5%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 14.9 34.7 42.8%  
FIIs % 2.9 24.2 11.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.1 53.4 47.1%  
Shareholders   455,624 312,473 145.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZYDUS LIFESCIENCES With:   DR. REDDYS LAB    SUN PHARMA    CIPLA    LUPIN    PIRAMAL ENTERPRISES    



Today's Market

Sensex Zooms 418 Points, Nifty Ends Above 17,900; Bajaj Twins and Bharti Airtel Rally(Closing)

After opening the day on a flat note, Indian share markets extended gains as the session progressed and ended near day's high.